Tag archive for ‘Brent Saunders’
By pharmanewsdaily On Thursday, May 7th, 2020

AbbVie acquisition of Allergan gets antitrust clearance from US FTC

AbbVie acquisition of Allergan update : US biopharma company AbbVie has secured clearance from the US Federal Trade Commission (FTC) for its previously announced $63 billion acquisition of Botox developer Allergan. According More...

By pharmanewsdaily On Sunday, September 16th, 2018

Allergan acquisition of Bonti : Allergan to acquire US aesthetic company in $195m deal

Allergan acquisition of Bonti : Irish pharma company Allergan will acquire Bonti, a US aesthetic company, engaged in the development of fast-acting neurotoxin programs for aesthetic and therapeutic applications, More...